Syed Kamal - Amer Renal President, Co-Founder, Director

President

Mr. Syed T. Kamal is President, CoFounder, Director of the Company. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has more than 36 years of experience in the dialysis services industry. Prior to founding our company, Mr. Kamal served in various management roles at FMCNA, including as President of FMCNA southern business unit, Vice President of Operations for FMCNA North America division, Director and Vice President of Operations for FMNCA International division and Regional Manager of FMNCA MidAtlantic and Southeast regions
Age 67
Professional MarksMBA
Phone978 922-3080
Webwww.americanrenal.com
Kamal holds a B.A. degree in Economics and Statistics and an M.B.A. degree from the University of Punjab in Pakistan.

Amer Renal Management Efficiency

The company has Return on Asset of 4.35 % which means that on every $100 spent on assets, it made $4.35 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 17.51 %, implying that it generated $17.51 on every 100 dollars invested. Amer Renal's management efficiency ratios could be used to measure how well Amer Renal manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 724.51 M in debt with debt to equity (D/E) ratio of 3.94, meaning that the company heavily relies on borrowing funds for operations. Amer Renal Assoc has a current ratio of 1.03, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist Amer Renal until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Renal's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Renal Assoc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Renal's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Thomas FlohnLincoln Electric Holdings
63
Bryan HanleyNL Industries
43
Hatsunori KiriyamaProcter Gamble
51
John SampsonDow Inc
63
Mathias HallmannLincoln Electric Holdings
52
Courtney RileyNL Industries
58
Paul DriscollAcme United
63
Douglas LanceLincoln Electric Holdings
55
Amy SamfordNL Industries
50
Charles PierceProcter Gamble
60
Jennifer AnsberryLincoln Electric Holdings
50
Heinz HallerDow Inc
61
Fernando RuizDow Inc
59
Mohamed SamirProcter Gamble
50
Peter HolickiDow Inc
58
Tarek FarahatProcter Gamble
51
Jack BroodoDow Inc
62
Brian OlschanAcme United
67
Clarence BrownNL Industries
51
Steven BishopProcter Gamble
56
Joe HarlanDow Inc
57
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. American Renal operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 4977 people. Amer Renal Assoc (ARA) is traded on New York Stock Exchange in USA and employs 4,977 people.

Management Performance

Amer Renal Assoc Leadership Team

Elected by the shareholders, the Amer Renal's board of directors comprises two types of representatives: Amer Renal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amer. The board's role is to monitor Amer Renal's management team and ensure that shareholders' interests are well served. Amer Renal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amer Renal's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason Boucher, Chief Accounting Officer, Vice President - Finance, Treasurer
Steven Silver, Independent Director
Patrick Ryan, Independent Director
Thomas Erickson, Independent Director
John Jureller, Independent Director
Jonathan Wilcox, CFO, Vice President
Michael Costa, Vice President General Counsel, Secretary
Robert Fish, Independent Director
Joseph Carlucci, Chairman of the Board, Chief Executive Officer, Co-Founder
Jeremy Gelber, Independent Director
Don Williamson, Chief Operating Officer, Executive Vice President
Christopher Hocevar, Independent Director
Syed Kamal, President, Co-Founder, Director
Jared Hendricks, Independent Director
John McDonough, COO, Executive Vice President Treasurer
Michael Boxer, Independent Director
Susanne Clark, Independent Director
Mark Herbers, Interim Chief Financial Officer, Interim Chief Accounting Officer

Amer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amer Renal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amer Renal in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amer Renal's short interest history, or implied volatility extrapolated from Amer Renal options trading.

Pair Trading with Amer Renal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Renal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Renal will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Exelon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exelon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exelon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exelon to buy it.
The correlation of Exelon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exelon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Amer Stock

If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account